Logo image of IPX

IPERIONX LTD - ADR (IPX) Stock Fundamental Analysis

NASDAQ:IPX - Nasdaq - US44916E1001 - ADR

25.21  -2.52 (-9.09%)

Fundamental Rating

3

Taking everything into account, IPX scores 3 out of 10 in our fundamental rating. IPX was compared to 154 industry peers in the Metals & Mining industry. While IPX seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, IPX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IPX has reported negative net income.
In the past year IPX has reported a negative cash flow from operations.
In the past 5 years IPX always reported negative net income.
IPX had a negative operating cash flow in each of the past 5 years.
IPX Yearly Net Income VS EBIT VS OCF VS FCFIPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

With a Return On Assets value of -39.40%, IPX is not doing good in the industry: 87.76% of the companies in the same industry are doing better.
The Return On Equity of IPX (-42.55%) is worse than 81.63% of its industry peers.
Industry RankSector Rank
ROA -39.4%
ROE -42.55%
ROIC N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
IPX Yearly ROA, ROE, ROICIPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPX Yearly Profit, Operating, Gross MarginsIPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

More info and screens

6

2. Health

2.1 Basic Checks

IPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IPX has been increased compared to 1 year ago.
The number of shares outstanding for IPX has been increased compared to 5 years ago.
IPX has a better debt/assets ratio than last year.
IPX Yearly Shares OutstandingIPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IPX Yearly Total Debt VS Total AssetsIPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 116.90 indicates that IPX is not in any danger for bankruptcy at the moment.
IPX's Altman-Z score of 116.90 is amongst the best of the industry. IPX outperforms 97.28% of its industry peers.
IPX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
IPX's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. IPX outperforms 70.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 116.9
ROIC/WACCN/A
WACC11.15%
IPX Yearly LT Debt VS Equity VS FCFIPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 13.62 indicates that IPX has no problem at all paying its short term obligations.
The Current ratio of IPX (13.62) is better than 92.52% of its industry peers.
IPX has a Quick Ratio of 13.61. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 13.61, IPX belongs to the best of the industry, outperforming 92.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.62
Quick Ratio 13.61
IPX Yearly Current Assets VS Current LiabilitesIPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

IPX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.42%.
Looking at the last year, IPX shows a quite strong growth in Revenue. The Revenue has grown by 10.43% in the last year.
The Revenue has been growing by 78.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)3.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.98%
Revenue 1Y (TTM)10.43%
Revenue growth 3Y375.46%
Revenue growth 5Y78.71%
Sales Q2Q%13.26%

3.2 Future

IPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 65.23% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y54.25%
EPS Next 2Y6.64%
EPS Next 3Y42.87%
EPS Next 5Y65.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPX Yearly Revenue VS EstimatesIPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
IPX Yearly EPS VS EstimatesIPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPX Price Earnings VS Forward Price EarningsIPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPX Per share dataIPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as IPX's earnings are expected to grow with 42.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.64%
EPS Next 3Y42.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IPX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IPERIONX LTD - ADR

NASDAQ:IPX (1/22/2025, 4:30:02 PM)

25.21

-2.52 (-9.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-27 2024-09-27
Earnings (Next)N/A N/A
Inst Owners29.59%
Inst Owner Change-1.47%
Ins Owners13.71%
Ins Owner ChangeN/A
Market Cap737.90M
Analysts80
Price Target30.13 (19.52%)
Short Float %0.24%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.34%
PT rev (3m)47.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)41.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-44.13%
Revenue NY rev (3m)-32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1351.4
P/FCF N/A
P/OCF N/A
P/B 14.37
P/tB 14.37
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.91
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.02
BVpS1.75
TBVpS1.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.4%
ROE -42.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1477.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.62
Quick Ratio 13.61
Altman-Z 116.9
F-Score4
WACC11.15%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)909.11%
Cap/Sales(5y)2910.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.98%
EPS Next Y54.25%
EPS Next 2Y6.64%
EPS Next 3Y42.87%
EPS Next 5Y65.23%
Revenue 1Y (TTM)10.43%
Revenue growth 3Y375.46%
Revenue growth 5Y78.71%
Sales Q2Q%13.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.33%
EBIT Next 3Y59.71%
EBIT Next 5Y69.61%
FCF growth 1Y-43.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.29%
OCF growth 3YN/A
OCF growth 5YN/A